There’s A Gap In Treatment For Sickle Cell Disease. This Small Biotech Company Might Fill It.

There are very few treatments for the disease and a cure through gene-editing is years off. But Global Blood Therapeutics has created a drug that could offer hope to those with sickle cell.

from Kaiser Health News https://ift.tt/2HVyVsM